Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer
Open Access
- 26 April 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 13, 778850
Abstract
Background: It has been reported that thymidine kinase 1 (TK1) was up-regulated in multiple malignancies and participated in the regulation of tumor malignant behavior. However, its specific role in prostate cancer (PCa) remains unclear.Methods: TK1 expression in PCa patients and cell lines was identified via crossover analysis of the public datasets. A series of in vitro experiments and in vivo models was applied to investigate the function of TK1 in PCa. Functional enrichment analyses were further conducted to explore the underlying mechanism. Additionally, TISIDB was applied to explore the correlation between TK1 expression and tumor-infiltrating lymphocytes, immune subtypes, and immune regulatory factors.Results: TK1 expression was significantly up-regulated in PCa patients and cell lines. TK1 ablation inhibited tumor cell proliferation and migration potential, and in vivo experiments showed that TK1 inactivation can significantly restrain tumor growth. Functional enrichment analysis revealed TK1-related hub genes (AURKB, CCNB2, CDC20, CDCA5, CDK1, CENPA, CENPM, KIF2C, NDC80, NUF2, PLK1, SKA1, SPC25, ZWINT), and found that TK1 was closely involved in the regulation of cell cycle. Moreover, elevated mRNA expression of TK1 was related with higher Gleason score, higher clinical stage, higher pathological stage, higher lymph node stage, shorter overall survival, and DFS in PCa patients. Particularly, TK1 represented attenuated expression in C3 PCa and was related with infiltration of CD4+, CD8+ T cells, and dendritic cells as well as immunomodulator expression.Conclusion: Our study indicates that TK1 is a prognostic predictor correlated with poor outcomes of PCa patients, and for the first time represented that TK1 can promote the progression of PCa. Therefore, TK1 may be a potential diagnostic and prognostic biomarker, as well as a therapeutic target for PCa.Keywords
Funding Information
- National Natural Science Foundation of China (91959114 81872106 81802573)
This publication has 53 references indexed in Scilit:
- Thymidine Kinase 1 Upregulation Is an Early Event in Breast Tumor FormationJournal of Oncology, 2012
- The mutational landscape of lethal castration-resistant prostate cancerNature, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Towards a knowledge-based Human Protein AtlasNature Biotechnology, 2010
- Regulation and Functional Contribution of Thymidine Kinase 1 in Repair of DNA DamageJournal of Biological Chemistry, 2010
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Thymidine Kinase 1 is a Potential Marker for Prognosis and Monitoring the Response to Treatment of Patients with Breast, Lung, and Esophageal Cancer and Non-Hodgkin's LymphomaNucleosides, Nucleotides & Nucleic Acids, 2010
- Structure and function of cellular deoxyribonucleoside kinasesCellular and Molecular Life Sciences, 2002
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002
- Regulation of thymidine kinase enzyme level in serum-stimulated mouse 3T6 fibroblasts*1Experimental Cell Research, 1982